Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Recurrence × plitidepsin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 4 Neoplasms 2 Lymphoma 2 Leukemia 2 Recurrence 1 Prostatic Neoplasms 1 Neoplasms, Plasma Cell 1 Neoplasm Metastasis 1 Liposarcoma 1

Interventions

Cyclophosphamide 31 Dexamethasone 28 Cytarabine 20 Rituximab 19 fludarabine phosphate 18 Lenalidomide 17 Methotrexate 15 Bortezomib 15 fludarabine 14 Calcium Dobesilate 14 Whole-Body Irradiation 13 pembrolizumab 12 Peripheral Blood Stem Cell Transplantation 12 Mycophenolic Acid 12 Etoposide 12 Melphalan 11 Gemcitabine 11 Filgrastim 11 Cyclosporine 11 Paclitaxel 10 pomalidomide 9 Carboplatin 9 Vincristine 8 Panobinostat 8 Clofarabine 8 Cetuximab 8 Busulfan 8 Brentuximab Vedotin 8 Bevacizumab 8 carfilzomib 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01876043 2021-01-25

APLIPO

Institut Bergonié

Phase 2 Terminated

24 enrolled 10 charts

Liposarcoma, Neoplasm Metastasis, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡